Acetylcholine and metacognition during sleep.
Jarrod A Gott, Sina Stücker, Philipp Kanske, Jan Haaker, Martin Dresler
Consciousness and cognition January 1, 2024 DOI: 10.1016/j.concog.2023.103608 via PubMed
Summary
AI-generated from the abstractAcetylcholine, a neurotransmitter involved in cognition and REM sleep regulation, may play a role in lucid dreaming—a state where metacognitive awareness returns during sleep. Recent studies using acetylcholinesterase inhibitors suggest a link, but the causal mechanisms remain unknown. This review examines theories connecting acetylcholine and metacognition across wakefulness and sleep, analyzing the phenomenon at microscopic, mesoscopic, and macroscopic levels. It develops exploratory hypotheses to guide future research on how acetylcholine receptor activity affects metacognition.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Lucid dreaming |
| Keywords | Acetylcholine Metacognition Rem sleep |
| Citations | 22 |
| Key finding | Acetylcholine may be involved in lucid dreaming, but the causal mechanisms remain unmodelled and unknown. |
Abstract
Acetylcholine is a neurotransmitter and neuromodulator involved in a variety of cognitive functions. Additionally, acetylcholine is involved in the regulation of REM sleep: cholinergic neurons in the brainstem and basal forebrain project to and innervate wide areas of the cerebral cortex, and reciprocally interact with other neuromodulatory systems, to produce the sleep-wake cycle and different sleep stages. Consciousness and cognition vary considerably across and within sleep stages, with metacognitive capacity being strikingly reduced even during aesthetically and emotionally rich dream experiences. A notable exception is the phenomenon of lucid dreaming-a rare state whereby waking levels of metacognitive awareness are restored during sleep-resulting in individuals becoming aware of the fact that they are dreaming. The role of neurotransmitters in these fluctuations of consciousness and cognition during sleep is still poorly understood. While recent studies using acetylcholinesterase inhibitors suggest a potential role of acetylcholine in the occurrence of lucid dreaming, the underlying mechanisms by which this effect is produced remains un-modelled and unknown; with the causal link between cholinergic mechanisms and upstream psychological states being complex and elusive. Several theories and approaches targeting the association between acetylcholine and metacognition during wakefulness and sleep are highlighted in this review, moving through microscopic, mesoscopic and macroscopic levels of analysis to detail this phenomenon at several organisational scales. Several exploratory hypotheses will be developed to guide future research towards fully articulating how metacognition is affected by activity at the acetylcholine receptor.